European Archives - Page 116 of 1345 - European Medical Journal

11 Sep 2025

Choosing an Inhaled Corticosteroid/ Inhaled Long-Acting β2-Agonist for Your Patients with Moderate Asthma

Asthma causes substantial morbidity and mortality worldwide.1 Steps 3 and 4 of the Global Initiative for Asthma (GINA) strategy recommend…

EMJ's Latest Autumn Journal

The 2025 edition of our flagship journal is out now – featuring all the latest insights you need to know across healthcare. From the…

EMJ 10.3 2025

Featuring diverse content across multiple therapeutic areas, this issue focusing on advancements in genomics, an area with the potential to..

Next-Gen Neurology: Emerging Therapeutic Strategies in Neuromuscular Diseases

MG primarily involves pathogenic autoantibodies targeting the post-synaptic membrane of neuromuscular junctions (NMJ)…

Portable Spacer Benefits Patients with Respiratory Disease

Spacers or valved holding chambers added to pressurised metered dose inhalers (pMDI) reduce errors in inhaler technique and improve…

Engineering the Future of Healthcare Through DNA: Interview with Sir Mark Caulfield

We are entering an era of precision healthcare, where genomics and other -omic tests, which are measures of your RNA, proteins…

Development of Phage Therapies for Acne Vulgaris

Acne vulgaris, commonly known as acne, is a skin disease caused by the blockage of hair follicles, high keratin and sebum production in…

Predicting Prostate Cancer in PI-RADS 1–2 Lesions

Prostate cancer remains one of the most prevalent malignancies among men worldwide, underscoring the need for effective diagnostic…

Anti-IL-23 Blocks Pathogenic T Cells

Psoriasis affects 60 million people globally. It is an inflammatory skin condition that can significantly impact quality of life…

A Case of Retroperitoneal Leiomyosarcoma of the Inferior Vena Cava

Leiomyosarcoma (LMS) is a malignant neoplasm characterised by smooth muscle differentiation. It is the second most common sarcoma to…